A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

Inclusion Criteria: * Healthy participants aged 19 to 55 years at the time of screening visit * Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit Exclusion Criteria: * Participants who have received an investigational product in another clinical trial or a bioequivalence study within 6 months prior to the first dosing * Participants deemed unsuitable for participation in this clinical trial by the investigator